Player FM 앱으로 오프라인으로 전환하세요!
Introducing Backtable Tumor Board
Manage episode 461450881 series 2658136
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
---
This podcast is supported by an educational grant from:
AstraZeneca
https://www.astrazeneca.com/our-therapy-areas/oncology.html
With additional support from:
Boston Scientific
https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html
---
SYNPOSIS
The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.
---
TIMESTAMPS
00:00 - Introduction
00:46 - Multidisciplinary Tumor Board
06:00 - Patient Experience in Treatment Pathways
10:10 - Barriers to Treatment
16:03 - Benefits of IR Clinic
19:33 - HCC Screening and Risk Factors
24:08 - Building Referral Networks
30:34 - Strategies for Effective Scheduling
35:43 - The Future of HCC Treatment
533 에피소드
Manage episode 461450881 series 2658136
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
---
This podcast is supported by an educational grant from:
AstraZeneca
https://www.astrazeneca.com/our-therapy-areas/oncology.html
With additional support from:
Boston Scientific
https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html
---
SYNPOSIS
The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.
---
TIMESTAMPS
00:00 - Introduction
00:46 - Multidisciplinary Tumor Board
06:00 - Patient Experience in Treatment Pathways
10:10 - Barriers to Treatment
16:03 - Benefits of IR Clinic
19:33 - HCC Screening and Risk Factors
24:08 - Building Referral Networks
30:34 - Strategies for Effective Scheduling
35:43 - The Future of HCC Treatment
533 에피소드
همه قسمت ها
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.